Correlation Between Fennec Pharmaceuticals and SAB Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Fennec Pharmaceuticals and SAB Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fennec Pharmaceuticals and SAB Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fennec Pharmaceuticals and SAB Biotherapeutics, you can compare the effects of market volatilities on Fennec Pharmaceuticals and SAB Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fennec Pharmaceuticals with a short position of SAB Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fennec Pharmaceuticals and SAB Biotherapeutics.
Diversification Opportunities for Fennec Pharmaceuticals and SAB Biotherapeutics
-0.28 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Fennec and SAB is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Fennec Pharmaceuticals and SAB Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SAB Biotherapeutics and Fennec Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fennec Pharmaceuticals are associated (or correlated) with SAB Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SAB Biotherapeutics has no effect on the direction of Fennec Pharmaceuticals i.e., Fennec Pharmaceuticals and SAB Biotherapeutics go up and down completely randomly.
Pair Corralation between Fennec Pharmaceuticals and SAB Biotherapeutics
Given the investment horizon of 90 days Fennec Pharmaceuticals is expected to generate 3.29 times less return on investment than SAB Biotherapeutics. But when comparing it to its historical volatility, Fennec Pharmaceuticals is 4.1 times less risky than SAB Biotherapeutics. It trades about 0.2 of its potential returns per unit of risk. SAB Biotherapeutics is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest 5.00 in SAB Biotherapeutics on August 30, 2024 and sell it today you would earn a total of 1.83 from holding SAB Biotherapeutics or generate 36.6% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 86.96% |
| Values | Daily Returns |
Fennec Pharmaceuticals vs. SAB Biotherapeutics
Performance |
| Timeline |
| Fennec Pharmaceuticals |
| SAB Biotherapeutics |
Fennec Pharmaceuticals and SAB Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Fennec Pharmaceuticals and SAB Biotherapeutics
The main advantage of trading using opposite Fennec Pharmaceuticals and SAB Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fennec Pharmaceuticals position performs unexpectedly, SAB Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SAB Biotherapeutics will offset losses from the drop in SAB Biotherapeutics' long position.| Fennec Pharmaceuticals vs. Molecular Partners AG | Fennec Pharmaceuticals vs. MediciNova | Fennec Pharmaceuticals vs. Anebulo Pharmaceuticals | Fennec Pharmaceuticals vs. Champions Oncology |
| SAB Biotherapeutics vs. SAB Biotherapeutics | SAB Biotherapeutics vs. Jasper Therapeutics | SAB Biotherapeutics vs. NRx Pharmaceuticals | SAB Biotherapeutics vs. Surrozen Warrant |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |